Department of Internal Medicine 2nd Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Erdem L, Akbal E, Koçak E.et al. A new risk-scoring system for colorectal cancer and polyp screening by Turkish colorectal cancer and polyp study group. Turk J Gastroenterol. 2022;33(4):286 293. 10.5152/tjg.2022.21072) PubMed DOI PMC

Luo S, Li JY, Zhao LN.et al. Diabetes mellitus increases the risk of colorectal neoplasia: an updated metaanalysis. Clin Res Hepatol Gastroenterol. 2016;40(1):110 123. 10.1016/j.clinre.2015.05.021) PubMed DOI

Ali Khan U, Fallah M, Sundquist K, Sundquist J, Brenner H, Kharazmi E. Risk of colorectal cancer in patients with diabetes ­mellitus: a Swedish nationwide cohort study. PLoS Med. 2020;17(11):e1003431. 10.1371/journal.pmed.1003431) PubMed DOI PMC

Romanová A, Malinovská J, Lustigová M.et al. Kolorektální karcinom u pacientů s diabetes mellitus - epidemiologie, patofyziologie a implikace pro praxi. Vnitr Lek. 2022;68(2):116 122. 10.36290/vnl.2022.022) PubMed DOI

Romanová A, Šťovíček J, Brož J. A new risk-scoring system for colorectal cancer and polyp screening. Turk J Gastroenterol. 2022;33(12):1079 1080. PubMed PMC

Erdem L, Akbal E, Koçak E.et al. A new risk-scoring system for colorectal cancer and polyp screening by Turkish colorectal cancer and polyp study group. Turk J Gastroenterol. 2022;33(4):286 293. (10.5152/tjg.2022.21072) PubMed DOI PMC

Cheng HC, Chang TK, Chihsu WC, Tsai HL, Wang JY. Narrative review of the influence of diabetes mellitus and hyperglycemia on colorectal cancer risk and oncological outcomes. Transl Oncol. 2021;6(7):101089. (10.1016/j.tranon.2021.101089) PubMed DOI PMC

Christou N, Bergen ES, Canton C.et al. Impact of diabetes and metformin use on recurrence and outcome in stage II-III colon cancer patients-A pooled analysis of three adjuvant trials. Eur J Cancer. 2022;166(166):100 111. (10.1016/j.ejca.2022.02.005) PubMed DOI

A New Risk-Scoring System for Colorectal Cancer and Polyp Screening